13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001674546
Total reported value
$4.8B
$4.8B
163 檔
29.3%
At the close of Q3 2024, Bellevue Group AG disclosed equity holdings valued at approximately $4.8B, spread across 163 reported holdings.
Bellevue Group AG executed strategic sector rebalancing during Q3 2024, establishing 12 new positions while fully exiting 15 holdings and trimming 71 positions.
In terms of portfolio concentration, the top 5 core holdings (including ARGX, IONS, VRTX) accounted for 29.3% of total reported equity market value during Q3 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ARGX | Argenx Se - Adr | Stock-Healthcare | 5.56% | +0.44% | -8.53% | |
| 2 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 5.11% | -1.63% | -4.67% | |
| 3 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 4.31% | -1.20% | -3.72% | |
| 4 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.95% | -1.01% | -7.99% | |
| 5 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 3.61% | -1.84% | -12.04% | |
| 6 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 3.58% | +0.56% | -3.14% | |
| 7 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 3.48% | +0.08% | -1.83% | |
| 8 | BSX | Boston Scientific CORP | Stock-Healthcare | 3.33% | -1.39% | -4.55% | |
| 9 | ABT | Abbott Laboratories | Stock-Healthcare | 3.22% | -1.00% | +8.58% | |
| 10 | SYK | Stryker CORP | Stock-Healthcare | 3.08% | +0.08% | -3.54% | |
| 11 | ITCIEUR | Intra-cellular Therapies Inc | Stock-Other | 2.95% | — | +0.58% | |
| 12 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 2.69% | — | -3.70% | |
| 13 | INCY | Incyte CORP | Stock-Healthcare | 2.30% | — | -0.14% | |
| 14 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 2.14% | +0.35% | +9.66% | |
| 15 | MRNA | Moderna Inc | Stock-Healthcare | 1.73% | — | +2.37% | |
| 16 | CLDX | Celldex Therapeutics Inc | Stock-Other | 1.69% | +0.03% | +3.37% | |
| 17 | BHVN | Biohaven Ltd. | Stock-Other | 1.65% | — | — | |
| 18 | EXK | Exact Sciences CORP | Stock-Materials | 1.60% | — | +25.07% | |
| 19 | CDNA | Caredx Inc | Stock-Other | 1.59% | — | -19.61% | |
| 20 | PODD | Insulet CORP | Stock-Healthcare | 1.59% | -0.41% | -3.20% | |
| 21 | MDT | Medtronic plc | Stock-Healthcare | 1.47% | -0.33% | +0.69% | |
| 22 | BDX | Becton Dickinson And Co | Stock-Healthcare | 1.32% | -0.11% | -2.79% | |
| 23 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 1.27% | — | +19.93% | |
| 24 | EVH | Evolent Health Inc - A | Stock-Other | 1.22% | — | +59.90% | |
| 25 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.21% | -0.19% | -10.03% | |
| 26 | DXCM | Dexcom Inc | Stock-Healthcare | 1.10% | -0.01% | -19.84% | |
| 27 | ARVN | Arvinas Inc | Stock-Other | 0.95% | — | -0.18% | |
| 28 | PEN | Penumbra Inc | Stock-Healthcare | 0.86% | -0.10% | EXIT | |
| 29 | RLAY | Relay Therapeutics Inc | Stock-Other | 0.85% | +0.59% | +15.68% | |
| 30 | OPCH | Option Care Health Inc | Stock-Healthcare | 0.84% | — | +16.80% | |
| 31 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.81% | -0.37% | +2.10% | |
| 32 | PRCT | Procept Biorobotics CORP | Stock-Other | 0.80% | -0.06% | -8.42% | |
| 33 | EPIEUR | Essa Pharma Inc | Stock-Other | 0.77% | — | -0.13% | |
| 34 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 0.76% | -0.10% | -3.62% | |
| 35 | HCA | Hca Healthcare Inc | Stock-Healthcare | 0.75% | -0.24% | -6.36% | |
| 36 | ELV | Elevance Health Inc | Stock-Healthcare | 0.75% | +0.09% | -12.03% | |
| 37 | IDXX | Idexx Laboratories Inc | Stock-Healthcare | 0.75% | -0.51% | -2.23% | |
| 38 | COO | Cooper Cos Inc/the | Stock-Healthcare | 0.71% | -0.16% | — | |
| 39 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.70% | — | +36.47% | |
| 40 | EXEL | Exelixis Inc | Stock-Healthcare | 0.67% | — | -11.27% | |
| 41 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 0.67% | -0.12% | EXIT | |
| 42 | CI | THE Cigna Group | Stock-Healthcare | 0.66% | -0.23% | -3.80% | |
| 43 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.64% | +0.01% | -10.93% | |
| 44 | RMD | Resmed Inc | Stock-Healthcare | 0.63% | -0.24% | +2.72% | |
| 45 | INSM | Insmed Inc | Stock-Healthcare | 0.62% | +3.09% | -48.57% | |
| 46 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 0.62% | -1.15% | EXIT | |
| 47 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 0.61% | -0.15% | +4.40% | |
| 48 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.60% | — | +7.05% | |
| 49 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.60% | — | — | |
| 50 | ALGN | Align Technology Inc | Stock-Healthcare | 0.59% | -0.07% | +0.01% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EXK | Exact Sciences CORP | +0.8% | +25.07% | Add |
| 2 | ARGX | Argenx Se - Adr | +0.7% | -8.53% | Trim |
| 3 | EVH | Evolent Health Inc - A | +0.7% | +59.90% | Add |
| 4 | CDNA | Caredx Inc | +0.6% | -19.61% | Trim |
| 5 | ABT | Abbott Laboratories | +0.5% | +8.58% | Add |
| 6 | BHVN | Biohaven Ltd. | +0.5% | — | Unchanged |
| 7 | UNH | Unitedhealth Group Inc | +0.4% | +9.66% | Add |
| 8 | RVMD | Revolution Medicines Inc | +0.4% | -3.14% | Trim |
| 9 | INSP | Inspire Medical Systems Inc | +0.4% | +56.41% | Add |
| 10 | BMRN | Biomarin Pharmaceutical Inc | +0.3% | +533.67% | Add |
| 11 | VRNA | Verona Pharma PLC - Adr | +0.3% | +7.57% | Add |
| 12 | TNDM | Tandem Diabetes Care Inc | +0.3% | +19.93% | Add |
| 13 | WVE | Wave Life Sciences Ltd. | +0.2% | — | Unchanged |
| 14 | ITCIEUR | Intra-cellular Therapies Inc | +0.2% | +0.58% | Add |
| 15 | OPCH | Option Care Health Inc | +0.2% | +16.80% | Add |
| 16 | EWTX | Edgewise Therapeutics Inc | +0.2% | — | Unchanged |
| 17 | MDT | Medtronic plc | +0.2% | +0.69% | Add |
| 18 | INCY | Incyte CORP | +0.2% | -0.14% | Trim |
| 19 | IQV | Iqvia Holdings Inc | +0.2% | +40.99% | Add |
| 20 | RLAY | Relay Therapeutics Inc | +0.2% | +15.68% | Add |
| 21 | PODD | Insulet CORP | +0.2% | -3.20% | Trim |
| 22 | TMO | Thermo Fisher Scientific Inc | +0.2% | +25.80% | Add |
| 23 | ONC | Beone Medicines Ltd-adr | +0.2% | +129.15% | Add |
| 24 | CSTL | Castle Biosciences Inc | +0.2% | +3.69% | Add |
| 25 | GEHC | GE Healthcare Technology | +0.2% | +2.10% | Add |
| 26 | RMD | Resmed Inc | +0.2% | +2.72% | Add |
| 27 | COO | Cooper Cos Inc/the | +0.2% | — | Unchanged |
| 28 | 430 | Terns Pharmaceuticals Inc | +0.1% | NEW | New buy |
| 29 | DHR | Danaher CORP | +0.1% | +25.82% | Add |
| 30 | PRCT | Procept Biorobotics CORP | +0.1% | -8.42% | Trim |
| 31 | NEO | Neogenomics Inc | +0.1% | +34.15% | Add |
| 32 | BSX | Boston Scientific CORP | +0.1% | -4.55% | Trim |
| 33 | HCA | Hca Healthcare Inc | +0.1% | -6.36% | Trim |
| 34 | JNJ | Johnson & Johnson | +0.1% | +557.20% | Add |
| 35 | EPIEUR | Essa Pharma Inc | +0.1% | -0.13% | Trim |
| 36 | GPCR | Structure Therapeutics Inc | +0.1% | +13.00% | Add |
| 37 | ANNX | Annexon Inc | +0.1% | — | Unchanged |
| 38 | ASTH | Astrana Health Inc | +0.1% | +1.42% | Add |
| 39 | SYK | Stryker CORP | +0.1% | -3.54% | Trim |
| 40 | BEAM | Beam Therapeutics Inc | +0.1% | +7.05% | Add |
| 41 | VEEV | Veeva Systems Inc-class A | +0.1% | -3.01% | Trim |
| 42 | ISRG | Intuitive Surgical Inc | +0.1% | -7.99% | Trim |
| 43 | SRPT | Sarepta Therapeutics Inc | +0.1% | +36.47% | Add |
| 44 | OMCL | Omnicell Inc | 0% | -16.00% | Trim |
| 45 | SIBN | Si-bone Inc | 0% | +4.07% | Add |
| 46 | PEN | Penumbra Inc | 0% | -3.32% | Trim |
| 47 | STE | STERIS plc | 0% | — | Unchanged |
| 48 | BMY | Bristol-myers Squibb Co | 0% | NEW | New buy |
| 49 | ALGN | Align Technology Inc | 0% | +0.01% | Add |
| 50 | HO1 | Hologic Inc | 0% | +0.02% | Add |
According to official SEC Form 13F filings, Bellevue Group AG reported a total U.S. public equity portfolio value of $4.8B across 163 disclosed positions in Q3 2024.
During Q3 2024, Bellevue Group AG's top holdings by market value included ARGX (5.6%)、IONS (5.1%)、VRTX (4.3%). The largest single position, ARGX, represented 5.6% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
Top New Position Initiated
430
市值: $8.7M
Top Position Liquidated / Trimmed
SILKUSD
前期市值: $23.1M
In Q3 2024, Bellevue Group AG made 155 total portfolio adjustments, initiating 12 new buys, adding to 57 positions, trimming 71 holdings, and fully liquidating 15 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.